SCHEMBL19986917

SCHEMBL19986917

[O-][S+]1CCN(c2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 11/20 0.75
PIM1 P11309 9/20 0.73
KCNH2 Q12809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986955 0.88 DYRK1A (0.81) DYRK1APIM1KCNH2
SCHEMBL22421458 0.88 DYRK1A (0.81) DYRK1APIM1KCNH2
SCHEMBL102136 0.84 PIM1 (1.00) DYRK1APIM1KCNH2
SCHEMBL140101 0.79 PIM1 (1.00) DYRK1APIM1KCNH2
SCHEMBL102861 0.79 PIM1 (1.00) DYRK1APIM1KCNH2
SCHEMBL19987030 0.79 PIM1 (0.78) PIM1KCNH2
SCHEMBL14653586 0.79 DYRK1A (0.73) DYRK1APIM1
SCHEMBL15699138 0.79 DYRK1A (0.76) DYRK1APIM1
SCHEMBL102421 0.78 DYRK1A (0.91) DYRK1APIM1
SCHEMBL19986921 0.77 PIM1 (0.79) PIM1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3812387-A1 HETEROCYCLIC PROTEIN KINASE INHIBITORS Sumitomo Dainippon Pharma Oncology, Inc. (US) 2021-04-28 EP disclosed
EP-3409278-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2020-09-16 EP disclosed
EP-2734205-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2018-03-21 EP disclosed